Quick highlights:
- Net Profit: $372m, down 9% YoY
- Revenue: $1,183m, up 1% YoY
- Australian revenue is down 1% due to a challenging market. Core Australian revenue: $1,104m
- Strong performance in REA India with revenue up 46% YoY
- EBITDA: $651m, down 3% YoY
- EPS: $2.82, down 9% YoY
- Full Year Dividend: $1.58/share, down 4% YoY
- Operating costs up 7% due to investments in India
- Forums
- ASX - By Stock
- REA
- Ann: Appendix 4E and Full Year Financial Report FY23
Ann: Appendix 4E and Full Year Financial Report FY23, page-2
-
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add REA (ASX) to my watchlist
|
|||||
Last
$191.50 |
Change
-1.250(0.65%) |
Mkt cap ! $25.30B |
Open | High | Low | Value | Volume |
$192.67 | $193.02 | $190.48 | $22.73M | 118.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 194 | $191.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$191.51 | 401 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 117 | 190.700 |
1 | 401 | 190.510 |
1 | 94 | 190.500 |
1 | 879 | 190.490 |
1 | 17 | 190.480 |
Price($) | Vol. | No. |
---|---|---|
191.510 | 401 | 2 |
191.590 | 117 | 1 |
191.660 | 401 | 1 |
191.820 | 401 | 1 |
191.860 | 9 | 1 |
Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
Featured News
REA (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online